Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lisa Amacker-North"'
Autor:
Lindsay McNeely, Kimberly Showers Foss, V. Brook White, Kendall Walsh, Stacy Lenarcic, Richard L. White, Lisa Amacker-North
Publikováno v:
The American Surgeon. 84:154-160
Genetic testing is important for comprehensive cancer care. Commercial analysis of the BRCA1/2 genes has been available since 1996, and testing for hereditary breast and ovarian cancer syndrome is well established. The National Comprehensive Cancer N
Autor:
Karinn Marie Chambers, Richard L. White, Teresa S. Flippo-Morton, Danielle Boselli, Kendall Walsh, Brook White, Lisa Amacker-North, Terry Sarantou
Publikováno v:
The Breast Journal. 22:35-44
A retrospective study was performed to document the uptake and extent of surgical intervention in patients with a known mutation in the BRCA1/2 genes and associated outcomes. Data were collected retrospectively on BRCA-positive patients with and with
Autor:
Lisa Amacker-North, Mohamed E. Salem, William M. Worrilow, Aly Athens, Lindsay McNeely, Edward S. Kim, Mariah Gleason, Sara Elrefai, Katherine Broyhill, Alberto Puccini
Publikováno v:
Journal of Clinical Oncology. 38:e13660-e13660
e13660 Background: The efficacy of PARP inhibitors in germline BRCA-mutated pancreatic adenocarcinoma (PC) and immune checkpoint inhibitors in dMMR colorectal cancer (CRC) shows the importance of genetic testing. We aimed to characterize the frequenc
Autor:
Aly Athens, Lisa Amacker-North, Sara Elrefai, Kunal C. Kadakia, Kelly Warsinske, Edward S. Kim, Mohamed E. Salem
Publikováno v:
Journal of Clinical Oncology. 38:676-676
676 Background: Results from the POLO trial demonstrated the benefits of PARP inhibition in patients (pts) with germline BRCA-mutated metastatic pancreatic cancer (PC). In 2018, ASCO and NCCN updated their guidelines to recommend that pts with a pers
Autor:
Claire Harwood, Lindsay McNeely, Beth Dellinger, Carolyn S. Menendez, Lisa Amacker-North, Kendall W. Carpenter, Brook White, Richard L. White, Kimberly Showers, Stacy Lenarcic
Publikováno v:
Journal of Clinical Oncology. 33:1552-1552
1552 Background: Genetic testing is an important component of comprehensive cancer care. Testing for hereditary breast and ovarian cancer syndrome is well established, as commercial analysis of the...
Autor:
Richard L. White, Terry Sarantou, Brook White, Karinn Marie Chambers, Edward Joey Armstrong, Frederick L. Greene, Teresa Flippo, Lisa Amacker-North, Wendy G. Brick
Publikováno v:
Journal of Clinical Oncology. 30:57-57
57 Background: A woman with a known BRCA mutation has a lifetime risk for the development of breast cancer of up to 80%. Carolinas Medical Center cares for approximately 600 breast cancer patients annually with genetic testing offered to those patien